01-02-2005 | Research Article
New drugs for colorectal cancer (irinotecan, oxaliplatin, raltitrexed) meet expectations in routine practice
A single center’s experience before and after their introduction
Published in: Journal of Gastrointestinal Cancer | Issue 1/2005
Login to get access